Randomized Phase 2 Open-Label Study of R-CHOP ± Bortezomib in Patients (Pts) With Untreated Non-Germinal Center B-Cell-like (Non-GCB) Subtype Diffuse Large Cell Lymphoma (DLBCL): Results From the Pyramid Trial (NCT00931918).
暂无分享，去创建一个
J. Leonard | K. Kolibaba | J. Reeves | A. Tulpule | I. Flinn | T. Kolevska | R. Robles | C. Flowers | R. Collins | N. DiBella | S. Papish | P. Venugopal | A. Horodner | Amir Tabatabai | J. Hajdenberg | R. Neuwirth | G. Mulligan | K. Suryanarayan | D. Esseltine | S. Vos